Recent studies (including one from Harvard Medical School) have found a potential link between semaglutide (the active ingredient in Ozempic/Wegovy) and a condition called NAION, which causes sudden, painless, and often permanent blindness in one eye. This is a newer claim in the lawsuits but is being taken very seriously.